Welcome to the SINFONIA Newsletter!
Table of contents
The SINFONIA project aims at developing novel methodologies and tools that will provide a comprehensive risk appraisal for detrimental effects of radiation exposure on patients, workers, carers and comforters, the public and the environment during the management of patients suspected or diagnosed with lymphoma and brain tumours.
Latest activities and results
During the second year of the project, completed in August 2022, one of the main activities has been the organisation of courses which aimed at training young clinicians, medical physicists, radiobiologists and other healthcare professionals as a team, encouraging the exchange of skills and knowledge within Europe.
Regarding the risks associated with radiation exposure of workers, including maintenance and technical personnel, a survey was conducted in 17 proton therapy centres across Europe to evaluate current doses and practices for this type of therapy. Overall, the results obtained confirm that good radiation protection are in place and the risk for staff working in proton therapy does not raise major concerns.
The impact on human and biota from the release of radiopharmaceuticals by hospitals was also assessed, using as case study the river network in Belgium. The results show that both routine and accidental releases under the scenarios considered in the study do not pose risks for humans or the environment.
The data repository of the project has also been released and is currently being tested with real data. The platform is designed in the first instance to facilitate data sharing between partners and in the next stage, selected machine learning algorithms will be implemented for data analyses directly on the platform.